• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2006 - 2012年中国女性宫颈癌死亡率及其时间趋势分析]

[Analysis on mortality of cervical cancer and its temporal trend in women in China, 2006-2012].

作者信息

Bao H L, Liu Y N, Wang L J, Fang L W, Cong S, Zhou M G, Wang L H

机构信息

Division of Cancer Control and Prevention, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Diseases Control and Prevention, Beijing 100050, China.

Division of Vital Statistics and Death Surveillance, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Diseases Control and Prevention, Beijing 100050, China.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jan 10;38(1):58-64. doi: 10.3760/cma.j.issn.0254-6450.2017.01.011.

DOI:10.3760/cma.j.issn.0254-6450.2017.01.011
PMID:28100378
Abstract

To analyze the mortality of cervical cancer and its temporal trend in women in China between 2006 and 2012. The cause-of-death data about cervical cancer, which was abstracted from National Disease Surveillance Points and adjusted by special survey for underreporting, was used to analyze the age and area specific crude mortality rates of cervical cancer in China during 2006-2012. The age-standardized mortality rate was calculated by using world standardized population (Segi's). The Joinpoint regression model was used to obtain annual percentage change and 95 for assessing the time trend of mortality rate of cervical cancer from 2006 to 2012. In 2012, the crude mortality rate of cervical cancer was 3.15 per 100 000 in women in China. The mortality rate in rural area (3.45/100 000) was higher than that in urban area (2.76/100 000), while the central area had the highest mortality rate of cervical cancer (3.77/100 000) compared with western area (3.23/100 000) and eastern area (2.54/100 000). The Segi's age-standardized mortality rate in eastern area increased by 2.9 (95: 0.8-5.0) annually, an increase of 6.0 was observed in age group 30-59 years (95: 1.6-10.5). However, the Segi's age-standardized mortality rate in central area declined by 4.6 (95: -5.9 - -3.3), where the declines of 3.2 and 5.7 were observed in age groups 30-59 years and ≥60 years (95: - 5.0-- 1.4 and 95: - 9.3 --2.0) and respectively. There was no significant change in cervical cancer mortality in western area. The similar trends were observed in the age-standardized mortality rate calculated according to the population of China. The decline of overall mortality rate of cervical cancer tended to stop in China and significant differences still exist among different areas. Our results suggest that the central/western areas and rural areas are still key areas for cervical cancer prevention and control and close attention should be paid to the increase of cervical cancer mortality in women aged 35-59 years in eastern area. It is essential to establish a systematic cervical cancer prevention network with larger population coverage to reduce the deaths caused by cervical cancer.

摘要

分析2006年至2012年中国女性宫颈癌死亡率及其时间趋势。从国家疾病监测点提取并经漏报专项调查调整的宫颈癌死因数据,用于分析2006 - 2012年中国宫颈癌的年龄别和地区别粗死亡率。采用世界标准人口(Segi氏人口)计算年龄标准化死亡率。使用Joinpoint回归模型获得年度百分比变化及95%可信区间,以评估2006年至2012年宫颈癌死亡率的时间趋势。2012年,中国女性宫颈癌粗死亡率为十万分之3.15。农村地区死亡率(十万分之3.45)高于城市地区(十万分之2.76),中部地区宫颈癌死亡率最高(十万分之3.77),高于西部地区(十万分之3.23)和东部地区(十万分之2.54)。东部地区Segi氏年龄标准化死亡率每年上升2.9(95%可信区间:0.8 - 5.0),30 - 59岁年龄组上升6.0(95%可信区间:1.6 - 10.5)。然而,中部地区Segi氏年龄标准化死亡率下降4.6(95%可信区间: - 5.9 - - 3.3),30 - 59岁和≥60岁年龄组分别下降3.2和5.7(95%可信区间: - 5.0 - - 1.4和95%可信区间: - 9.3 - - 2.0)。西部地区宫颈癌死亡率无显著变化。根据中国人口计算的年龄标准化死亡率也观察到类似趋势。中国宫颈癌总体死亡率下降趋势趋于停滞,不同地区仍存在显著差异。我们的结果表明,中西部地区和农村地区仍是宫颈癌防控的重点区域,应密切关注东部地区35 - 59岁女性宫颈癌死亡率的上升。建立覆盖人群更广的系统性宫颈癌预防网络以减少宫颈癌所致死亡至关重要。

相似文献

1
[Analysis on mortality of cervical cancer and its temporal trend in women in China, 2006-2012].[2006 - 2012年中国女性宫颈癌死亡率及其时间趋势分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jan 10;38(1):58-64. doi: 10.3760/cma.j.issn.0254-6450.2017.01.011.
2
[Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008].1989 - 2008年中国女性宫颈癌发病率与死亡率的趋势分析
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014 Apr;36(2):119-25. doi: 10.3881/j.issn.1000-503X.2014.02.001.
3
[Incidence and mortality of cervical cancer in China, 2014].[2014年中国宫颈癌的发病率与死亡率]
Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):241-246. doi: 10.3760/cma.j.issn.0253-3766.2018.04.001.
4
[Report of breast cancer incidence and mortality in China registry regions, 2008-2012].[2008 - 2012年中国登记地区乳腺癌发病与死亡报告]
Zhonghua Zhong Liu Za Zhi. 2019 Apr 23;41(4):315-320. doi: 10.3760/cma.j.issn.0253-3766.2019.04.013.
5
[Analysis on the alterative trend of colorectal cancer mortality from 1999 to 2015 in Tianjin of China].[1999年至2015年中国天津市结直肠癌死亡率变化趋势分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jun 25;22(6):579-586. doi: 10.3760/cma.j.issn.1671-0274.2019.06.012.
6
[Report of Cancer Incidence and Mortality in China, 2014].《2014年中国癌症发病与死亡报告》
Zhonghua Zhong Liu Za Zhi. 2018 Jan 23;40(1):5-13. doi: 10.3760/cma.j.issn.0253-3766.2018.01.002.
7
[Incidence and mortality of endometrial cancer in China, data from China Cancer Registry Annual Report, 2004-2017].[中国子宫内膜癌的发病率和死亡率,数据来自《中国癌症登记年报》,2004 - 2017年]
Zhonghua Yi Xue Za Zhi. 2024 Mar 12;104(10):721-728. doi: 10.3760/cma.j.cn112137-20231017-00784.
8
Incidence and mortality of cervical cancer in China in 2015.2015年中国宫颈癌的发病率和死亡率。
J Natl Cancer Cent. 2022 Feb 3;2(2):70-77. doi: 10.1016/j.jncc.2022.01.002. eCollection 2022 Jun.
9
Colorectal cancer incidence and mortality in China, 2010.2010年中国结直肠癌的发病率和死亡率
Asian Pac J Cancer Prev. 2014;15(19):8455-60. doi: 10.7314/apjcp.2014.15.19.8455.
10
[Estimation on the incidence and mortality of kidney cancer in China, in 2014].[2014年中国肾癌发病率及死亡率估计]
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Oct 10;39(10):1346-1350. doi: 10.3760/cma.j.issn.0254-6450.2018.10.011.

引用本文的文献

1
Analysis of Xinjiang HPV16 L1 gene polymorphisms: a newly developed, low-cost enzyme-linked immunosorbent assay.新疆人乳头瘤病毒16型L1基因多态性分析:一种新开发的低成本酶联免疫吸附测定法。
Int J Clin Exp Pathol. 2022 Jan 15;15(1):1-10. eCollection 2022.
2
Serum Tie-1 is a Valuable Marker for Predicting the Progression and Prognosis of Cervical Cancer.血清 Tie-1 是预测宫颈癌进展和预后的有价值标志物。
Pathol Oncol Res. 2021 Dec 17;27:1610006. doi: 10.3389/pore.2021.1610006. eCollection 2021.
3
The better effects of microbubble ultrasound transfection of miR-940 on cell proliferation inhibition and apoptosis promotion in human cervical cancer cells.
微小RNA-940的微泡超声转染对人宫颈癌细胞增殖抑制和凋亡促进的更好效果。
Onco Targets Ther. 2019 Aug 21;12:6813-6824. doi: 10.2147/OTT.S209692. eCollection 2019.
4
Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset.中国个体层面和地理层面社会经济地位指标与宫颈癌筛查率的显著差异:基于全国代表性调查数据集的多层次模型分析。
Cancer Med. 2018 May;7(5):2089-2100. doi: 10.1002/cam4.1321. Epub 2018 Mar 24.